Tag: vosoritide

Netherlands

BioMarin to Present Data Showing Long-Term Benefit of VOXZOGO® (vosoritide) on Growth in Children with Achondroplasia at 2023 European Society for Paediatric Endocrinology (ESPE) Meeting

1 year ago
BusinessL

[ad_1] Label Expansion Decisions Expected from U.S. and European Regulatory Authorities in Q4 SAN RAFAEL, Calif., Sept. 21, 2023 /PRNewswire/ — BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company…

Opinion

BioMarin Receives Positive CHMP Opinion in Europe to Expand Use of VOXZOGO® (vosoritide) to Treat Children Aged 4 Months and Older with Achondroplasia

1 year ago
BusinessL

[ad_1] European Commission Approval Decision Expected Q4 2023 Opinion Based on Positive Results from Global Phase 2 and Ongoing Extension Study  U.S. Food and Drug Administration PDUFA Target Action Date for…

You Missed

Business Line

What is Employee Sentiment Analysis?

6 months ago
xtw183877bca
Business Line

Exploring Amazon’s New AI Chatbot: How Rufus is Changing the Shopping Experience

6 months ago
xtw183877bca
Business Line

Rezolve AI Partners with ePages to Bring AI Powered Conversational Commerce to over 100,000 Merchants Globally RZLV Stock News

6 months ago
xtw183877bca

Has Sweden got its coronavirus science right? – BBC News

7 months ago
BusinessL